Nobuo Sasai
Kanagawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Efficacy and Safety of Alogliptin in Elderly Patients With Type 2 Diabetes Mellitus.
Journal: Journal of clinical medicine research
Published: August 14, 2019
Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study.
Journal: Journal of clinical medicine research
Published: November 02, 2018
Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study.
Journal: Journal of clinical medicine research
Published: May 25, 2017
Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus.
Journal: Journal of clinical medicine research
Published: April 11, 2017
Factors Influencing Changes in Hemoglobin A1c and Body Weight During Treatment of Type 2 Diabetes With Ipragliflozin: Interim Analysis of the ASSIGN-K Study.
Journal: Journal of clinical medicine research
Published: February 15, 2016
Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study.
Journal: Journal of clinical medicine research
Published: January 20, 2016
Efficacy and Safety of Alogliptin in Patients With Type 2 Diabetes: Analysis of the ATTAK-J Study.
Journal: Journal of clinical medicine research
Published: December 04, 2015
Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study.
Journal: Journal of clinical medicine research
Published: November 24, 2015
Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study.
Journal: Journal of clinical medicine research
Published: March 19, 2015
Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.
Journal: BMC endocrine disorders
Published: March 10, 2015
Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes.
Journal: Clinical pharmacology : advances and applications
Published: May 17, 2014
Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: the ASSIST-K study.
Journal: Diabetes research and clinical practice
Published: September 06, 2013
Last Updated: 09/26/2026